Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2012-10-15

FDA Approved: IRBESARTAN — Original Application (Alembic Pharmaceuticals Limited)

View source ↗

Summary

FDA approved Alembic Pharmaceuticals Limited's original ANDA for irbesartan, a generic angiotensin II receptor blocker for hypertension and diabetic nephropathy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Irbesartan (irbesartan)

Snippet

ORIG AP for IRBESARTAN (IRBESARTAN)